You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Exercise Disclosure
Robinson James A. Jr. · SEC Form 4 · Filed Aug 28, 2026
Exercise
Reported value range
Not reported
Robinson James A. Jr. Director
URGN
UroGen Pharma Ltd
URGN
Transaction date
Aug 26, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 2 days later
URGN daily price context
Close on/before transaction
$45.94
Aug 26, 2026
First close after public filing
$43.09
Aug 31, 2026
30-day return after filing
-5.08%
Through Sep 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- ordinary shares
- Quantity / price
- 2,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-029175
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN Current | Exercise | Aug 26, 2026 | Not reported |
| Urogen Pharma Ltd. URGN | Exercise | Aug 26, 2026 | $0 |